(Q39259096)

10 September 2017

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy (English)

1 reference

10 September 2017

0 references

1 reference

1 reference

9

Mitsune Tanimoto

1 reference

10 September 2017

10

Katsuyuki Kiura

1 reference

10 September 2017

2

Nagio Takigawa

1 reference

10 September 2017

7

Eiki Ichihara

1 reference

10 September 2017

6

Nobuaki Ochi

1 reference

10 September 2017

8

Hiromichi Yamane

1 reference

10 September 2017

1

Toshio Kubo

1 reference

10 September 2017

4

Daijiro Harada

1 reference

10 September 2017

3

Masahiro Osawa

1 reference

10 September 2017

Takashi Ninomiya

5

1 reference

PubMed ID

23066953

10 September 2017

language of work or name

1 reference

24 November 2012

1 reference

10 September 2017

1 reference

10 September 2017

104

1 reference

10 September 2017

1

1 reference

10 September 2017

78-84

1 reference

PubMed ID

23066953

describes a project that uses

10 September 2017

0 references

0 references

0 references

0 references

0 references

0 references

Prospective identification of tumorigenic breast cancer cells

1 reference

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

CD13 is a therapeutic target in human liver cancer stem cells

21 January 2018

1 reference

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

21 January 2018

1 reference

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

Cancer stem cells and the ontogeny of lung cancer

21 January 2018

1 reference

Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.

21 January 2018

1 reference

Identification of uPAR-positive chemoresistant cells in small cell lung cancer

21 January 2018

1 reference

The urokinase receptor as a potential target in cancer therapy.

21 January 2018

1 reference

Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy

21 January 2018

1 reference

Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.

21 January 2018

1 reference

Characterization of the enzymes involved in the in vitro metabolism of amrubicin hydrochloride

21 January 2018

1 reference

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells

21 January 2018

1 reference

Molecular mechanisms of cisplatin resistance

21 January 2018

1 reference

Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.

21 January 2018

1 reference

12 December 2020

CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients

1 reference

12 December 2020

Combination chemotherapy with or without radiation therapy in small cell lung cancer. An analysis of a 5-year follow-up

1 reference

12 December 2020

Classical resistance mechanisms.

1 reference

12 December 2020

Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell line.

1 reference

12 December 2020

Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line

1 reference

12 December 2020

Cytotoxicity of activated natural killer cells and expression of adhesion molecules in small-cell lung cancer

1 reference

12 December 2020

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

1 reference

12 December 2020

Small cell lung cancer can express CD34 antigen.

1 reference

12 December 2020

Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.

1 reference

12 December 2020

Establishment and characterization of an adriamycin-resistant subline of human small cell lung cancer cells

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12045

1 reference

10 September 2017

1 reference

PubMed ID

23066953